Press release
Global Dermatophytic Onychomycosis Market Estimated to Account for US$ 4,706.3 Million by the End of 2021
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the forecast period. By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for about 70% share of the total global dermatophytic onychomycosis market revenue by 2021. By distribution channels, the market is segmented into hospitals, dermatology and podiatry clinics, independent pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are estimated to be largest segment with 47% share of the total global market revenue by 2015 end. The drug stores segment is expected to register the fastest CAGR during the forecast period. Independent pharmacies are projected to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2015 end.
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
This report covers global and regional trends along with an analysis of the market potential. North America is expected to account for over 43% revenue share of the total dermatophytic onychomycosis therapeutics market by 2015 end i.e. holding the maximum market share. Whereas Europe is projected to grow at a healthy CAGR of 7.3% due to increasing awareness about fungal nail infections.
Global dermatophytic onychomycosis therapeutics market report begins with an overview of the global market in terms of value. This section includes detailed analysis of key trends, drivers and restraints, and opportunities. All of these are factors that impact market growth. Impact analysis of key growth drivers and restraints based on the weighted average of each one of these factors in a model-based approach is included in the market report to better equip clients with crystal clear decision-making insights.
A Sample of this report is available upon request @ www.persistencemarketresearch.com/samples/5840
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
To Buy Full Report for a Single User @ www.persistencemarketresearch.com/checkout/5840
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Dermatophytic Onychomycosis Market Estimated to Account for US$ 4,706.3 Million by the End of 2021 here
News-ID: 526917 • Views: …
More Releases from Persistence Market Research
Garbage Collection Trucks Market Expected to Surpass US$ 20,049.9 Million by 203 …
The garbage collection trucks market is witnessing a significant uptrend as urbanization, population growth, and the increasing need for effective waste management solutions drive demand worldwide. According to Persistence Market Research, the global market size is anticipated to grow from US$ 15,032.7 million in 2025 to US$ 20,049.9 million by 2032, reflecting a CAGR of 4.2% during the forecast period. Garbage collection trucks, also referred to as waste collection vehicles,…
Investments in Port and Logistics Infrastructure Propel Shipping Containers Mark …
The shipping containers market is a critical component of global trade and logistics, facilitating the seamless movement of goods across countries. According to Persistence Market Research, the market is projected to reach US$10.2 billion in 2032, up from US$7.8 billion in 2025, expanding at a CAGR of 3.8% during the forecast period. The growth is closely tied to investments in port and logistics infrastructure, which enhance container handling efficiency and…
Rising Recreational Boating and Technological Advancements Accelerate Outboard E …
The outboard engines market is poised for remarkable growth in the coming years, driven by technological advancements, electrification, and an increasing global appetite for marine recreational activities. According to Persistence Market Research, the global outboard engines market is projected to grow from US$ 5,469.1 million in 2025 to US$ 8,279.6 million by 2032, reflecting a CAGR of 6.1%. This robust growth trajectory highlights the rising demand for efficient, environmentally friendly,…
Automotive Parts Aftermarket Outlook 2023-2033: Key Players Like Bosch, Denso, M …
The Automotive Parts Aftermarket has become a critical component of the global automotive ecosystem. According to Persistence Market Research, the market size reached US$ 548.5 billion in 2022 and is projected to expand to US$ 576.5 billion in 2023. With the replacement parts segment expected to achieve a total value of US$ 984.7 billion by 2033, the market is set to grow at a CAGR of 5.5% from 2023 to…
More Releases for Dermatophytic
Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031).
Presence and availability of a large clinical pipeline with reference to therapeutic approaches based…
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027".
The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is…
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic…
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the…
